Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127868) titled 'Evaluation of the Efficacy and Safety of an Automated Insulin Delivery System in Patients with Type 1 Diabetes: A Multicenter, Open-Label, Randomized, Parallel-Group Controlled Clinical Trial' on July 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of University of Science and Technology of China
Condition:
Type 1 diabetes
Intervention:
Intervention group:Participants will receive treatment with an artificial pancreas system. The artificial pancreas system consists of a continuous glucose monitoring device, an insulin pump, and a glucose control alg...